Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients

Fumihiko Koiwa, Daisuke Komukai, Makoto Hirose, Ashio Yoshimura, Ryoichi Ando, Toshifumi Sakaguchi, Yasuhiro Komatsu, Toshio Shinoda, Daijo Inaguma, Nobuhiko Joki, Hidemi Nishida, Masato Ikeda, Takashi Shigematsu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Introduction: The aim of this study was to investigate the factors influencing serum parathyroid (PTH) levels, including medications for treating chronic kidney disease-mineral and bone metabolism disorder (CKD-MBD) in patients with end-stage renal disease. Methods: We enrolled 1,076 patients in nine Japanese facilities who had begun hemodialysis (HD) due to ESRD. We investigated the relationships between intact PTH (iPTH) levels and clinical parameters and medications just prior to beginning HD. Results: Significant decreases in serum iPTH levels were seen in males, in the presence of diabetes mellitus (DM), and with administration of renin-angiotensin system inhibitors (RASIs). Significant correlations were found between serum calcium and iPTH levels. In the patients administered RASIs, there was a significant decrease in serum iPTH levels with DM, male gender, and administration of active vitamin D sterols (VDs) compared with those not administered RASIs, although serum-corrected calcium levels were not different. Multiple regression analysis found gender, age, presence of DM, and serum calcium and phosphate levels to be significant contributing factors. In addition, administration of angiotensin II receptor blockers (ARBs) may also be a contributing factor to iPTH levels at the beginning HD (p = 0.050). Conclusion: In this study, serum iPTH levels were related to administration of ARBs besides gender, age, the presence of DM and serum calcium levels. Our study suggests that the RA system involve serum iPTH levels in uremic patients.

Original languageEnglish
Pages (from-to)130-135
Number of pages6
JournalClinical and Experimental Nephrology
Volume16
Issue number1
DOIs
Publication statusPublished - 01-02-2012
Externally publishedYes

Fingerprint

Renin-Angiotensin System
Parathyroid Hormone
Serum
Diabetes Mellitus
Renal Dialysis
Angiotensin Receptor Antagonists
Calcium
Chronic Kidney Failure
Chronic Kidney Disease-Mineral and Bone Disorder
Sterols
Vitamin D
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Physiology (medical)

Cite this

Koiwa, F., Komukai, D., Hirose, M., Yoshimura, A., Ando, R., Sakaguchi, T., ... Shigematsu, T. (2012). Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients. Clinical and Experimental Nephrology, 16(1), 130-135. https://doi.org/10.1007/s10157-011-0534-x
Koiwa, Fumihiko ; Komukai, Daisuke ; Hirose, Makoto ; Yoshimura, Ashio ; Ando, Ryoichi ; Sakaguchi, Toshifumi ; Komatsu, Yasuhiro ; Shinoda, Toshio ; Inaguma, Daijo ; Joki, Nobuhiko ; Nishida, Hidemi ; Ikeda, Masato ; Shigematsu, Takashi. / Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients. In: Clinical and Experimental Nephrology. 2012 ; Vol. 16, No. 1. pp. 130-135.
@article{f0aef9806a7e4a8a8b1111c849cf3833,
title = "Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients",
abstract = "Introduction: The aim of this study was to investigate the factors influencing serum parathyroid (PTH) levels, including medications for treating chronic kidney disease-mineral and bone metabolism disorder (CKD-MBD) in patients with end-stage renal disease. Methods: We enrolled 1,076 patients in nine Japanese facilities who had begun hemodialysis (HD) due to ESRD. We investigated the relationships between intact PTH (iPTH) levels and clinical parameters and medications just prior to beginning HD. Results: Significant decreases in serum iPTH levels were seen in males, in the presence of diabetes mellitus (DM), and with administration of renin-angiotensin system inhibitors (RASIs). Significant correlations were found between serum calcium and iPTH levels. In the patients administered RASIs, there was a significant decrease in serum iPTH levels with DM, male gender, and administration of active vitamin D sterols (VDs) compared with those not administered RASIs, although serum-corrected calcium levels were not different. Multiple regression analysis found gender, age, presence of DM, and serum calcium and phosphate levels to be significant contributing factors. In addition, administration of angiotensin II receptor blockers (ARBs) may also be a contributing factor to iPTH levels at the beginning HD (p = 0.050). Conclusion: In this study, serum iPTH levels were related to administration of ARBs besides gender, age, the presence of DM and serum calcium levels. Our study suggests that the RA system involve serum iPTH levels in uremic patients.",
author = "Fumihiko Koiwa and Daisuke Komukai and Makoto Hirose and Ashio Yoshimura and Ryoichi Ando and Toshifumi Sakaguchi and Yasuhiro Komatsu and Toshio Shinoda and Daijo Inaguma and Nobuhiko Joki and Hidemi Nishida and Masato Ikeda and Takashi Shigematsu",
year = "2012",
month = "2",
day = "1",
doi = "10.1007/s10157-011-0534-x",
language = "English",
volume = "16",
pages = "130--135",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "1",

}

Koiwa, F, Komukai, D, Hirose, M, Yoshimura, A, Ando, R, Sakaguchi, T, Komatsu, Y, Shinoda, T, Inaguma, D, Joki, N, Nishida, H, Ikeda, M & Shigematsu, T 2012, 'Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients', Clinical and Experimental Nephrology, vol. 16, no. 1, pp. 130-135. https://doi.org/10.1007/s10157-011-0534-x

Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients. / Koiwa, Fumihiko; Komukai, Daisuke; Hirose, Makoto; Yoshimura, Ashio; Ando, Ryoichi; Sakaguchi, Toshifumi; Komatsu, Yasuhiro; Shinoda, Toshio; Inaguma, Daijo; Joki, Nobuhiko; Nishida, Hidemi; Ikeda, Masato; Shigematsu, Takashi.

In: Clinical and Experimental Nephrology, Vol. 16, No. 1, 01.02.2012, p. 130-135.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients

AU - Koiwa, Fumihiko

AU - Komukai, Daisuke

AU - Hirose, Makoto

AU - Yoshimura, Ashio

AU - Ando, Ryoichi

AU - Sakaguchi, Toshifumi

AU - Komatsu, Yasuhiro

AU - Shinoda, Toshio

AU - Inaguma, Daijo

AU - Joki, Nobuhiko

AU - Nishida, Hidemi

AU - Ikeda, Masato

AU - Shigematsu, Takashi

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Introduction: The aim of this study was to investigate the factors influencing serum parathyroid (PTH) levels, including medications for treating chronic kidney disease-mineral and bone metabolism disorder (CKD-MBD) in patients with end-stage renal disease. Methods: We enrolled 1,076 patients in nine Japanese facilities who had begun hemodialysis (HD) due to ESRD. We investigated the relationships between intact PTH (iPTH) levels and clinical parameters and medications just prior to beginning HD. Results: Significant decreases in serum iPTH levels were seen in males, in the presence of diabetes mellitus (DM), and with administration of renin-angiotensin system inhibitors (RASIs). Significant correlations were found between serum calcium and iPTH levels. In the patients administered RASIs, there was a significant decrease in serum iPTH levels with DM, male gender, and administration of active vitamin D sterols (VDs) compared with those not administered RASIs, although serum-corrected calcium levels were not different. Multiple regression analysis found gender, age, presence of DM, and serum calcium and phosphate levels to be significant contributing factors. In addition, administration of angiotensin II receptor blockers (ARBs) may also be a contributing factor to iPTH levels at the beginning HD (p = 0.050). Conclusion: In this study, serum iPTH levels were related to administration of ARBs besides gender, age, the presence of DM and serum calcium levels. Our study suggests that the RA system involve serum iPTH levels in uremic patients.

AB - Introduction: The aim of this study was to investigate the factors influencing serum parathyroid (PTH) levels, including medications for treating chronic kidney disease-mineral and bone metabolism disorder (CKD-MBD) in patients with end-stage renal disease. Methods: We enrolled 1,076 patients in nine Japanese facilities who had begun hemodialysis (HD) due to ESRD. We investigated the relationships between intact PTH (iPTH) levels and clinical parameters and medications just prior to beginning HD. Results: Significant decreases in serum iPTH levels were seen in males, in the presence of diabetes mellitus (DM), and with administration of renin-angiotensin system inhibitors (RASIs). Significant correlations were found between serum calcium and iPTH levels. In the patients administered RASIs, there was a significant decrease in serum iPTH levels with DM, male gender, and administration of active vitamin D sterols (VDs) compared with those not administered RASIs, although serum-corrected calcium levels were not different. Multiple regression analysis found gender, age, presence of DM, and serum calcium and phosphate levels to be significant contributing factors. In addition, administration of angiotensin II receptor blockers (ARBs) may also be a contributing factor to iPTH levels at the beginning HD (p = 0.050). Conclusion: In this study, serum iPTH levels were related to administration of ARBs besides gender, age, the presence of DM and serum calcium levels. Our study suggests that the RA system involve serum iPTH levels in uremic patients.

UR - http://www.scopus.com/inward/record.url?scp=84858276072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858276072&partnerID=8YFLogxK

U2 - 10.1007/s10157-011-0534-x

DO - 10.1007/s10157-011-0534-x

M3 - Article

VL - 16

SP - 130

EP - 135

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 1

ER -